Florian Kühnel

5PUBLICATIONS
4CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 09, 2025
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.

Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz

|Jan 09, 2025
Oncolytic viruses expressing MATEs facilitate target-independent T-cell activation in tumors.

Malin Peter, Bettina Mundt, Arne Menze

|Nov 21, 2019
Live vaccines-a short-cut to cancer viro-immunotherapy.

Thomas C Wirth, Julia Niemann, Florian Kühnel

|Jul 21, 2019
Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy.

Julia Niemann, Norman Woller, Jennifer Brooks

|Jul 14, 2017
Oncolytic viruses: adenoviruses.

Julia Niemann, Florian Kühnel

Pageof 1